FDA-approved & Passed Phase I Drug Library
Catalog No.L3800
Offered in 96 or 384 well plate format

A unique collection of 3177 drugs that are marketed around the world or have passed clinical phase 1 and can be used for high throughput screening (HTS) and high content screening (HCS).
Selleck Chemicals compound library contributes and expedites
the investigation of treatments against COVID19
The researchers at the National Institute of Infectious Diseases, in Japan, successfully found anti-COVID19 drugs within 3 months of
screening FDA-approved drug library from Selleck Chemicals. They have already published this article doi: 10.1101/2020.04.14.039925.
You Could Select:
FDA-approved & Passed Phase I Drug Library Contents
Case Studies using Selleck Compound Libraries
-
Application of Epigenetics Compound Library in acute lymphoblastic leukemia
Blood. 2019 17;134(16):1323-1336
Description & Advantages
• A unique collection of 3177 drugs that are marketed around the world or have passed clinical phase 1 and can be used for high throughput screening (HTS) and high content screening (HCS)
•Drug repurposing, the application of known drugs to treat new disease indication, holds potential of rapid clinical impact at a lower cost than de novo drug development
• Safety confirmed by clinical phase 1
• Related to oncology, cardiology, anti-inflammatory, immunology, neuropsychiatry, analgesia etc
• Structurally diverse, medicinally active, and cell permeable.
• Rich documentation with structure, IC50, and customer reviews
• NMR and HPLC validated to ensure the highest purity
Product Details
Formulation: | 2825 compounds pre-dissolved in 10mM DMSO, 248 compounds pre-dissolved in 10mM water, 86 compounds pre-dissolved in 2mM DMSO and 18 compounds pre-dissolved in 2mM water |
---|---|
Container: | 96 Well Format Sample Storage Tube With Screw Cap and Optional 2D Barcode |
Stability: | in DMSO |
in DMSO | |
Shipping: | Blue ice or dry ice |